How can I lose belly fat?

Targeting fat loss specifically in the abdominal area—often referred to as “spot reduction”—is a common misconception. Scientific evidence consistently shows that it is not possible to selectively burn fat from one part of the body through localized exercise or dietary interventions. Abdominal fat, whether subcutaneous (under the skin) or visceral (deep within the abdomen surrounding internal organs), decreases only as part of overall body fat reduction.

Effective, sustainable abdominal fat reduction requires a multifaceted approach grounded in evidence-based lifestyle medicine. This includes caloric deficit achieved through balanced, nutrient-dense nutrition—emphasizing whole foods, adequate protein, fiber-rich vegetables and fruits, and minimizing added sugars and ultra-processed carbohydrates. Regular physical activity is essential: aerobic exercise (e.g., brisk walking, cycling, swimming) for at least 150 minutes per week at moderate intensity helps create energy expenditure, while resistance training two or more days per week preserves lean muscle mass, which supports resting metabolic rate.

Additionally, sleep hygiene, stress management, and consistent circadian rhythms play critical physiological roles—chronic sleep deprivation and elevated cortisol levels are independently associated with increased visceral adiposity. For individuals with central obesity, waist circumference ≥102 cm (40 inches) in men or ≥88 cm (35 inches) in women warrants clinical evaluation, as it may signal elevated cardiometabolic risk—including insulin resistance, dyslipidemia, hypertension, and non-alcoholic fatty liver disease.

If abdominal fat persists despite sustained lifestyle efforts—or if accompanied by symptoms such as fatigue, unexplained weight gain, menstrual irregularities, or skin changes—a medical assessment is recommended to rule out endocrine conditions like Cushing syndrome, hypothyroidism, or polycystic ovary syndrome (PCOS). In select cases, pharmacotherapy or bariatric surgery may be considered under specialist supervision for individuals with obesity-related comorbidities.